{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "adds_modification",
    "modifications" : [ {
      "modification_type" : "phosphorylation"
    } ],
    "negative_information" : false,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "uniprot:P31749",
      "entity_text" : "PKB",
      "entity_type" : "protein"
    },
    "is_direct" : false,
    "hypothesis_information" : false,
    "context" : {
      "CellType" : [ "cl:CL:0000187" ],
      "Species" : [ "taxonomy:9606" ]
    }
  },
  "verbose_text" : "Specifically, treatment with the BRS-3 agonist at 10 -11 to 10 -8 M slightly increased the PKB phosphorylation levels (overall mean, 126 +/-2% of control; p < 0.02) l; these levels were lower (p < 0.0001) than those obtained by treatment with 10 -9 M insulin (XREF_FIG).",
  "reading_complete" : "2020-08-02T13:13:11Z",
  "reader_type" : "machine",
  "reading_started" : "2020-08-02T13:07:08Z",
  "trigger" : "phosphorylation",
  "evidence" : [ "PKB phosphorylation" ],
  "pmc_id" : "4356436",
  "score" : 0
}